390 related articles for article (PubMed ID: 32145072)
21. Transcriptional repression of SIRT1 by protein inhibitor of activated STAT 4 (PIAS4) in hepatic stellate cells contributes to liver fibrosis.
Sun L; Fan Z; Chen J; Tian W; Li M; Xu H; Wu X; Shao J; Bian Y; Fang M; Xu Y
Sci Rep; 2016 Jun; 6():28432. PubMed ID: 27323886
[TBL] [Abstract][Full Text] [Related]
22. Restoration of Sinusoid Fenestrae Followed by Targeted Nanoassembly Delivery of an Anti-Fibrotic Agent Improves Treatment Efficacy in Liver Fibrosis.
Li F; Zhao Y; Cheng Z; Wang Y; Yue Y; Cheng X; Sun J; Atabakhshi-Kashi M; Yao J; Dou J; Yu J; Zhang X; Qi Y; Li X; Qi X; Nie G
Adv Mater; 2023 Apr; 35(17):e2212206. PubMed ID: 36862807
[TBL] [Abstract][Full Text] [Related]
23. Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation.
Bates J; Vijayakumar A; Ghoshal S; Marchand B; Yi S; Kornyeyev D; Zagorska A; Hollenback D; Walker K; Liu K; Pendem S; Newstrom D; Brockett R; Mikaelian I; Kusam S; Ramirez R; Lopez D; Li L; Fuchs BC; Breckenridge DG
J Hepatol; 2020 Oct; 73(4):896-905. PubMed ID: 32376414
[TBL] [Abstract][Full Text] [Related]
24. Caveolin-1 is upregulated in hepatic stellate cells but not sinusoidal endothelial cells after liver injury.
Singh S; Liu S; Rockey DC
Tissue Cell; 2016 Apr; 48(2):126-32. PubMed ID: 26847875
[TBL] [Abstract][Full Text] [Related]
25. Fibronectin Type III Domain-Containing Protein 5 rs3480 A>G Polymorphism, Irisin, and Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
Petta S; Valenti L; Svegliati-Baroni G; Ruscica M; Pipitone RM; Dongiovanni P; Rychlicki C; Ferri N; Cammà C; Fracanzani AL; Pierantonelli I; Di Marco V; Meroni M; Giordano D; Grimaudo S; Maggioni M; Cabibi D; Fargion S; Craxì A
J Clin Endocrinol Metab; 2017 Aug; 102(8):2660-2669. PubMed ID: 28472477
[TBL] [Abstract][Full Text] [Related]
26. Paracrine activation of hepatic stellate cells in platelet-derived growth factor C transgenic mice: evidence for stromal induction of hepatocellular carcinoma.
Wright JH; Johnson MM; Shimizu-Albergine M; Bauer RL; Hayes BJ; Surapisitchat J; Hudkins KL; Riehle KJ; Johnson SC; Yeh MM; Bammler TK; Beyer RP; Gilbertson DG; Alpers CE; Fausto N; Campbell JS
Int J Cancer; 2014 Feb; 134(4):778-88. PubMed ID: 23929039
[TBL] [Abstract][Full Text] [Related]
27. Cell-specific PPARγ deficiency establishes anti-inflammatory and anti-fibrogenic properties for this nuclear receptor in non-parenchymal liver cells.
Morán-Salvador E; Titos E; Rius B; González-Périz A; García-Alonso V; López-Vicario C; Miquel R; Barak Y; Arroyo V; Clària J
J Hepatol; 2013 Nov; 59(5):1045-53. PubMed ID: 23831119
[TBL] [Abstract][Full Text] [Related]
28. Loss of discoidin domain receptor 2 promotes hepatic fibrosis after chronic carbon tetrachloride through altered paracrine interactions between hepatic stellate cells and liver-associated macrophages.
Olaso E; Arteta B; Benedicto A; Crende O; Friedman SL
Am J Pathol; 2011 Dec; 179(6):2894-904. PubMed ID: 22019896
[TBL] [Abstract][Full Text] [Related]
29. Conjugated secondary 12α-hydroxylated bile acids promote liver fibrogenesis.
Xie G; Jiang R; Wang X; Liu P; Zhao A; Wu Y; Huang F; Liu Z; Rajani C; Zheng X; Qiu J; Zhang X; Zhao S; Bian H; Gao X; Sun B; Jia W
EBioMedicine; 2021 Apr; 66():103290. PubMed ID: 33752128
[TBL] [Abstract][Full Text] [Related]
30. Origin of myofibroblasts in the fibrotic liver in mice.
Iwaisako K; Jiang C; Zhang M; Cong M; Moore-Morris TJ; Park TJ; Liu X; Xu J; Wang P; Paik YH; Meng F; Asagiri M; Murray LA; Hofmann AF; Iida T; Glass CK; Brenner DA; Kisseleva T
Proc Natl Acad Sci U S A; 2014 Aug; 111(32):E3297-305. PubMed ID: 25074909
[TBL] [Abstract][Full Text] [Related]
31. Interaction of non‑parenchymal hepatocytes in the process of hepatic fibrosis (Review).
Cheng QN; Yang X; Wu JF; Ai WB; Ni YR
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760176
[TBL] [Abstract][Full Text] [Related]
32. Endothelial GATA4 controls liver fibrosis and regeneration by preventing a pathogenic switch in angiocrine signaling.
Winkler M; Staniczek T; Kürschner SW; Schmid CD; Schönhaber H; Cordero J; Kessler L; Mathes A; Sticht C; Neßling M; Uvarovskii A; Anders S; Zhang XJ; von Figura G; Hartmann D; Mogler C; Dobreva G; Schledzewski K; Géraud C; Koch PS; Goerdt S
J Hepatol; 2021 Feb; 74(2):380-393. PubMed ID: 32916216
[TBL] [Abstract][Full Text] [Related]
33. Transcriptional regulation of Hepatic Stellate Cell activation in NASH.
Marcher AB; Bendixen SM; Terkelsen MK; Hohmann SS; Hansen MH; Larsen BD; Mandrup S; Dimke H; Detlefsen S; Ravnskjaer K
Sci Rep; 2019 Feb; 9(1):2324. PubMed ID: 30787418
[TBL] [Abstract][Full Text] [Related]
34. Single-Cell Transcriptomic Analysis Reveals a Hepatic Stellate Cell-Activation Roadmap and Myofibroblast Origin During Liver Fibrosis in Mice.
Yang W; He H; Wang T; Su N; Zhang F; Jiang K; Zhu J; Zhang C; Niu K; Wang L; Yuan X; Liu N; Li L; Wei W; Hu J
Hepatology; 2021 Nov; 74(5):2774-2790. PubMed ID: 34089528
[TBL] [Abstract][Full Text] [Related]
35. Single-cell and bulk transcriptomics of the liver reveals potential targets of NASH with fibrosis.
Wang ZY; Keogh A; Waldt A; Cuttat R; Neri M; Zhu S; Schuierer S; Ruchti A; Crochemore C; Knehr J; Bastien J; Ksiazek I; Sánchez-Taltavull D; Ge H; Wu J; Roma G; Helliwell SB; Stroka D; Nigsch F
Sci Rep; 2021 Sep; 11(1):19396. PubMed ID: 34588551
[TBL] [Abstract][Full Text] [Related]
36. CPEB4 Increases Expression of PFKFB3 to Induce Glycolysis and Activate Mouse and Human Hepatic Stellate Cells, Promoting Liver Fibrosis.
Mejias M; Gallego J; Naranjo-Suarez S; Ramirez M; Pell N; Manzano A; Suñer C; Bartrons R; Mendez R; Fernandez M
Gastroenterology; 2020 Jul; 159(1):273-288. PubMed ID: 32169429
[TBL] [Abstract][Full Text] [Related]
37. SIRT6 Protects Against Liver Fibrosis by Deacetylation and Suppression of SMAD3 in Hepatic Stellate Cells.
Zhong X; Huang M; Kim HG; Zhang Y; Chowdhury K; Cai W; Saxena R; Schwabe RF; Liangpunsakul S; Dong XC
Cell Mol Gastroenterol Hepatol; 2020; 10(2):341-364. PubMed ID: 32305562
[TBL] [Abstract][Full Text] [Related]
38. The orphan nuclear receptor COUP-TFII coordinates hypoxia-independent proangiogenic responses in hepatic stellate cells.
Ceni E; Mello T; Polvani S; Vasseur-Cognet M; Tarocchi M; Tempesti S; Cavalieri D; Beltrame L; Marroncini G; Pinzani M; Milani S; Galli A
J Hepatol; 2017 Apr; 66(4):754-764. PubMed ID: 27866920
[TBL] [Abstract][Full Text] [Related]
39. Liver X receptor α is essential for the capillarization of liver sinusoidal endothelial cells in liver injury.
Xing Y; Zhao T; Gao X; Wu Y
Sci Rep; 2016 Feb; 6():21309. PubMed ID: 26887957
[TBL] [Abstract][Full Text] [Related]
40. Hepatic stellate cells-specific LOXL1 deficiency abrogates hepatic inflammation, fibrosis, and corrects lipid metabolic abnormalities in non-obese NASH mice.
Yang A; Yan X; Fan X; Shi Y; Huang T; Li W; Chen W; Jia J; You H
Hepatol Int; 2021 Oct; 15(5):1122-1135. PubMed ID: 34014450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
